1. Home
  2. TTOO

TTOO

T2 Biosystems Inc.

Logo T2 Biosystems Inc.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-17-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.

Founded: 2006 Country:
United States
United States
Employees: N/A City: LEXINGTON
Market Cap: 16.7M IPO Year: 2014
Target Price: $7.00 AVG Volume (30 days): 250.6K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -19.19 EPS Growth: N/A
52 Week Low/High: $2.70 - $70.00 Next Earning Date: 05-13-2024
Revenue: $7,193,000 Revenue Growth: -67.75%
Revenue Growth (this year): 41.8% Revenue Growth (next year): 267.00%

Share on Social Networks: